386 related articles for article (PubMed ID: 30073324)
21. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
[TBL] [Abstract][Full Text] [Related]
22. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
Dono M; Angelini G; Cecconi M; Amaro A; Esposito AI; Mirisola V; Maric I; Lanza F; Nasciuti F; Viaggi S; Gualco M; Bandelloni R; Truini M; Coviello DA; Zupo S; Mosci C; Pfeffer U
Br J Cancer; 2014 Feb; 110(4):1058-65. PubMed ID: 24423917
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in prognostic and predictive testing in uveal melanoma.
Field MG; Harbour JW
Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
25. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
27. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.
Mudhar HS; Doherty RE; Salvi SM; Currie ZI; Tan JH; Sisley K
Ophthalmology; 2019 Jul; 126(7):1045-1052. PubMed ID: 30605742
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract][Full Text] [Related]
29. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
[TBL] [Abstract][Full Text] [Related]
30. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
31. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
Rose AM; Luo R; Radia UK; Kalirai H; Thornton S; Luthert PJ; Jayasena CN; Verity DH; Coupland SE; Rose GE
BMC Cancer; 2018 Dec; 18(1):1262. PubMed ID: 30558566
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
33. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW
JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399
[TBL] [Abstract][Full Text] [Related]
34. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
[TBL] [Abstract][Full Text] [Related]
35. Systematic genomic and translational efficiency studies of uveal melanoma.
Johnson CP; Kim IK; Esmaeli B; Amin-Mansour A; Treacy DJ; Carter SL; Hodis E; Wagle N; Seepo S; Yu X; Lane AM; Gragoudas ES; Vazquez F; Nickerson E; Cibulskis K; McKenna A; Gabriel SB; Getz G; Van Allen EM; 't Hoen PAC; Garraway LA; Woodman SE
PLoS One; 2017; 12(6):e0178189. PubMed ID: 28594900
[TBL] [Abstract][Full Text] [Related]
36. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
[TBL] [Abstract][Full Text] [Related]
38. New concepts in the molecular understanding of uveal melanoma.
Reichstein D
Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
40. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]